Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–51.
Article PubMed CAS Google Scholar
Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16:91–102.
Article PubMed CAS Google Scholar
Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48:6987–98.
Article PubMed PubMed Central CAS Google Scholar
Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol. 2019;10:1601.
Article PubMed PubMed Central Google Scholar
Chopra T, Marchaim D, Awali RA, Krishna A, Johnson P, Tansek R, Chaudary K, Lephart P, Slim J, Hothi J, Ahmed H, Pogue JM, Zhao JJ, Kaye KS. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother. 2013;57:6270–5.
Article PubMed PubMed Central CAS Google Scholar
Čiginskienė A, Dambrauskienė A, Rello J, Adukauskienė D. Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: risk factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality. Medicina. 2019;55:49.
Article PubMed PubMed Central Google Scholar
Heo ST, Oh WS, Kim SJ, Bae IG, Ko KS, Lee JC. Clinical impacts of a single clone (sequence type 92) of multidrug-resistant Acinetobacter baumannii in intensive care units. Microb Drug Resist. 2011;17:559–62.
Teerawattanapong N, Panich P, Kulpokin D, Ranong SN, Kongpakwattana K, Saksinanon A. A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2018;39:525–33.
Nasr P. Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. 2019;104:4–11.
Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197:1079–81.
WHO Bacterial Priority Pathogens List. 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024.
Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10:373.
Article PubMed PubMed Central CAS Google Scholar
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.
Article PubMed PubMed Central Google Scholar
Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35–40.
Article PubMed PubMed Central CAS Google Scholar
Moubareck CA, Halat DH, Nabi A, AlSharhan MA, AlDeesi ZO, Han A, Celiloglu H, Sarkis DK. Detection of OXA-23, GES-11 and NDM-1 among carbapenem-resistant Acinetobacter baumannii in Dubai: a preliminary study. J Glob Antimicrob Resist. 2021;24:27–8.
Maamar E, Alonso CA, Ferjani S, Jendoubi A, Hamzaoui Z, Jebri A, Saidani M, Ghedira S, Torres C. NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia. Int J Antimicrob Agents. 2018;52:910–5.
Article PubMed CAS Google Scholar
Raible KM, Sen B, Law N, Bias TE, Emery CL, Ehrlich GD, Joshi SG. Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob. 2017;16:75.
Article PubMed PubMed Central Google Scholar
Jun SH, Lee DE, Hwang HR, Kim N, Kwon KT, Kim YK, Lee JC. Clonal evolution and antimicrobial resistance of Acinetobacter baumannii isolates from Korean hospitals over the last decade. Infect Genet Evol. 2023;108: 105404.
Article PubMed CAS Google Scholar
Jun SH, Lee DE, Hwang HR, Kim N, Kim HJ, Lee YC, Kim YK, Lee JC. Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital. Infect Genet Evol. 2021;93: 104935.
Article PubMed CAS Google Scholar
Selasi GN, Nicholas A, Jeon H, Lee YC, Yoo JR, Heo ST, Lee JC. Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2015;36:1–7.
Article PubMed CAS Google Scholar
Zhu Y, Zhang X, Wang Y, Tao Y, Shao X, Li Y, Li W. Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children’s medical centre in eastern China. Ann Clin Microbiol Antimicrob. 2022;21:47.
Article PubMed PubMed Central CAS Google Scholar
Korczak L, Majewski P, Iwaniuk D, Sacha P, Matulewicz M, Wieczorek P, Majewska P, Wieczorek A, Radziwon P, Tryniszewska E. Molecular mechanisms of tigecycline-resistance among Enterobacterales. Front Cell Infect Microbiol. 2024;14:1289396.
Article PubMed PubMed Central CAS Google Scholar
Sun C, Yu Y, Hua X. Resistance mechanisms of tigecycline in Acinetobacter baumannii. Front Cell Infect Microbiol. 2023;13:1141490.
Article PubMed PubMed Central CAS Google Scholar
Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643.
Article PubMed PubMed Central Google Scholar
Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54:4971–7.
Article PubMed PubMed Central CAS Google Scholar
Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, Hazlett KRO, Doi Y, Ernst RK. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2013;57:4831–40.
Ko SY, Kim N, Park SY, Kim SY, Shin M, Lee JC. Acinetobacter baumannii under acidic conditions induces colistin resistance through PmrAB activation and lipid A modification. Antibiotics. 2023;12:813.
Article PubMed PubMed Central CAS Google Scholar
Islam MM, Jung DE, Shin WS, Oh MH. Colistin resistance mechanism and management strategies of colistin-resistant Acinetobacter baumannii infections. Pthogens. 2024;13:1049.
Alteri C, Teri A, Liporace MF, Muscatello A, Terranova L, Schianca MC, Salari F, Orena BS, Silverj FG, Bernazzani M, Biscarini S, Renisi G, Cariani L, Matinato C, Canetta C, Bandera A, Callegaro A. Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naive individuals. Ann Clin Microbiol Antimicrob. 2024;23:104.
Article PubMed PubMed Central CAS Google Scholar
Fernández-Cuenca F, Smani Y, Gómez-Sánchez MC, Docobo-Pérez F, Caballero-Moyano FJ, Domínguez-Herrera J, Pascual A, Pachón J. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. Int J Antimicrob Agents. 2011;38:548–9.
Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, Kim SA, Lee SK, Lee JC. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and
Comments (0)